Career Level: E

Be part of history in the making. AstraZeneca is building its first biologics manufacturing campus in Singapore — a groundbreaking USD 1.5 billion investment that will serve as a global hub for innovation and excellence.

This state‑of‑the‑art facility will deliver end‑to‑end Antibody‑Drug Conjugate (ADC) capabilities with different manufacturing units/buildings in one campus. Small molecule‑chemical API production, large molecule‑monoclonal antibody manufacturing, conjugation, fill‑and‑finish operations including sterile filling and lyophilization, and final secondary packaging.

• Large molecule- monoclonal antibody manufacturing

• Conjugation

• Fill-and-finish operations, including sterile filling and lyophilization

• Final secondary packaging

The campus...